Form 4: GoodRx Executive Romin Nabiey Reports Stock Transactions

Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Summary

• On September 8, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock and Restricted Stock Units.
• Nabiey acquired 10,201 shares of Class A Common Stock through the vesting of Restricted Stock Units.
• Nabiey disposed of 3,640 shares of Class A Common Stock at a price of $7.71.
• Nabiey also acquired 2,232 shares of Class A Common Stock through the vesting of additional Restricted Stock Units.
• Nabiey disposed of 797 shares of Class A Common Stock at a price of $7.71.
• Following these transactions, Nabiey directly owns 72,629 shares of Class A Common Stock.
• Nabiey also owns 81,606 Restricted Stock Units and 31,252 Restricted Stock Units.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by an executive, and doesn't inherently indicate positive or negative sentiment. It's a neutral event in isolation.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect the overall performance or outlook of GoodRx but offers insight into the actions of its executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in insider ownership.
• The transactions do not appear to have any impact on employees, customers, suppliers, or creditors.

Key Dates